ID
22310
Description
A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT01801436
Link
https://clinicaltrials.gov/show/NCT01801436
Keywords
Versions (1)
- 5/29/17 5/29/17 -
Uploaded on
May 29, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Myeloma NCT01801436
Eligibility Multiple Myeloma NCT01801436
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
prior therapy, bortezomib, progressive disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C1176309
- UMLS CUI [1,3]
- C1335499
Description
prior therapy bortezomib, serious adverse event
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C1176309
- UMLS CUI [1,3]
- C1519255
Description
nitrosoureas, prior chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C3540781
- UMLS CUI [2]
- C1514457
Description
steroid therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0149783
Description
hiv, hep b, hep c
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019682
- UMLS CUI [1,2]
- C0019163
- UMLS CUI [1,3]
- C0019196
Similar models
Eligibility Multiple Myeloma NCT01801436
- StudyEvent: Eligibility
C0026764 (UMLS CUI [1,2])
C0026764 (UMLS CUI [2,1])
C0035020 (UMLS CUI [2,2])
C1335499 (UMLS CUI [2,3])
C0815189 (UMLS CUI [2,4])
C0015787 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C1176309 (UMLS CUI [1,2])
C1335499 (UMLS CUI [1,3])
C1176309 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C1514457 (UMLS CUI [2])
C0019163 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])